Studies on the decontamination of surfaces exposed to cytotoxic drugs in chemotherapy workstations
dc.contributor.author | Sewell, GJ | |
dc.contributor.author | Roberts, S | |
dc.contributor.author | Khammo, N | |
dc.contributor.author | McDonnell, G | |
dc.date.accessioned | 2015-10-27T16:41:25Z | |
dc.date.available | 2015-10-27T16:41:25Z | |
dc.date.issued | 2006 | |
dc.identifier.issn | 1078-1552 | |
dc.identifier.issn | 1477-092X | |
dc.identifier.uri | http://hdl.handle.net/10026.1/3724 | |
dc.description.abstract |
<jats:p> Objective. The aim of this study was to examine the removal and deactivation of cytotoxic contamination from surfaces of a pharmaceutical isolator workstation. </jats:p><jats:p> Methods. Three marker cytotoxic drugs were evaluated in three phases using decontamination technologies currently available in the pharmaceutical and healthcare environments. Phase I investigated the physical removal of contamination by detergents. Phase II and III investigated the effectiveness of detergents and Vaporised Hydrogen Peroxide (VHP®) in degrading cytotoxic drugs, respectively. </jats:p><jats:p> Results. 5-Flurouracil, doxorubicin and cyclophosphamide were removed from a surface by wiping with detergents. VHP® and alkaline detergents caused degradation of doxorubicin. The observed effect with detergent cleaning was pH dependent, but neither of the technologies applied had any effect on the chemical stability of 5-flurouracil and cyclophosphamide under the conditions tested. </jats:p> | |
dc.format.extent | 95-104 | |
dc.format.medium | ||
dc.language | en | |
dc.language.iso | en | |
dc.publisher | SAGE Publications | |
dc.subject | Antineoplastic Agents | |
dc.subject | Chromatography, High Pressure Liquid | |
dc.subject | Cyclophosphamide | |
dc.subject | Decontamination | |
dc.subject | Detergents | |
dc.subject | Doxorubicin | |
dc.subject | Drug Therapy | |
dc.subject | Environmental Monitoring | |
dc.subject | Fluorouracil | |
dc.subject | Humans | |
dc.subject | Hydrogen Peroxide | |
dc.subject | Occupational Exposure | |
dc.subject | Oncology Service, Hospital | |
dc.subject | Pharmacy Service, Hospital | |
dc.subject | Workplace | |
dc.title | Studies on the decontamination of surfaces exposed to cytotoxic drugs in chemotherapy workstations | |
dc.type | journal-article | |
dc.type | Article | |
plymouth.author-url | https://www.ncbi.nlm.nih.gov/pubmed/16984748 | |
plymouth.issue | 2 | |
plymouth.volume | 12 | |
plymouth.publication-status | Published | |
plymouth.journal | Journal of Oncology Pharmacy Practice | |
dc.identifier.doi | 10.1177/1078155206070439 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy/UoA03 Allied Health Professions, Dentistry, Nursing and Pharmacy MANUAL | |
plymouth.organisational-group | /Plymouth/Research Groups | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Health and Community | |
plymouth.organisational-group | /Plymouth/Users by role | |
dc.publisher.place | England | |
dc.identifier.eissn | 1477-092X | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.1177/1078155206070439 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.type | Journal Article/Review |